首页 > 市场调查报告书 > 医疗设备

药物递输设备

市场调查报告书

商品编码

1672650

先进 DDS（药物传输系统）市场：按类型、按应用、按载体类型、按最终用户、按地区

Advanced Drug Delivery Systems Market, By Type, By Application, By Carrier Type, By End User, By Geography

出版日期: 2025年02月10日 | 出版商:

Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球先进 DDS（药物输送系统）市场规模预计为 2,694.8 亿美元，预计到 2032 年将达到 4027.9 亿美元，2025 年至 2032 年的复合年增长率为 5.9%。

报告范围		报告详细信息
基准年	2024	2025 年市场规模	2694.8亿美元
效能资料	从 2020 年到 2024 年	预测期	2025 至 2032 年
预测期：2025-2032年复合年增长率：	5.90％	2032 年价值预测	4027.9亿美元

数字。 2025 年各地区高级 DDS市场占有率（%）

先进的 DDS 使得新型配方的开发成为可能，可以将药物特异性定位到体内某个部位，进行局部和持续的治疗。奈米技术和其他工程方法促进了智慧运载载体的创造，例如胶束、树状聚合物、脂质体和聚合物奈米颗粒，它们可以保护药物免于降解并控制其释放。这种输送平台有助于提高许多药物的疗效并减少不良副作用，从而改善其治疗指数。先进的 DDS 能够跨越生物屏障精确地运送治疗有效载荷，从而彻底改变癌症和其他严重疾病的治疗。

市场动态：

先进的 DDS 市场受到针对性和可控药物输送日益增长的需求的推动。製药公司不断增加研发投入以开发创新配方，以及癌症等慢性病的发生率不断上升，推动市场的成长。然而，高昂的开发成本和监管问题对新参与企业构成了挑战。新兴国家尚未开发的潜力为市场扩张提供了机会。此外，长效注射剂等先进给药技术的持续扩展应用可能会为药物开发商开闢新的途径。

本研究的主要特点

本报告对全球先进 DDS 市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。

它还揭示了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。

它还提供了关于市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。

全球高级 DDS 市场的主要企业根据公司亮点、产品系列、关键亮点、业绩和策略等参数进行分析。

主要企业包括 Baxter 、 3M、Abbott、Datwyler Holding Inc.、Evonik、 Astra Zeneca 、Novo Nordisk A/S、Corium Innovations, Inc.、PolyActiva、Teleflex Incorporated、Elixir Medical、B. Braun SE、Nemera、Epion Therapeutics Inc.

本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。

本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

相关人员可以透过用于分析全球高阶 DDS 市场的各种策略矩阵更轻鬆地做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 269.48 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.90%	2032 Value Projection:	USD 402.79 Bn

Advanced drug delivery systems have enabled the development of novel formulations that can specifically target drugs to areas of the body for localized or sustained treatment. Nanotechnology and other engineering approaches have facilitated the creation of intelligent delivery vehicles like micelles, dendrimers, liposomes, and polymeric nanoparticles that can shield drugs from degradation and control their release. Such delivery platforms help improve the therapeutic index of many drugs by increasing their efficacy and reducing unwanted side effects. With their ability to cross biological barriers and precisely deliver therapeutic payloads, advanced drug delivery systems are revolutionizing the treatment of cancer and other serious diseases.

Market Dynamics:

The advanced drug delivery systems market is driven by the growing demand for targeted and controlled drug delivery. Increasing R&D investments by pharmaceutical companies to develop innovative formulations and the rising prevalence of chronic diseases like cancer are fueling market growth. However, high development costs and regulatory issues pose challenges to new entrants. The untapped potential of emerging economies presents an opportunity for market expansion. Additionally, the growing application scope of advanced delivery technologies like long-acting injectables could open new avenues for drug developers.

Key features of the study:

This report provides in-depth analysis of the global advanced drug delivery systems market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global advanced drug delivery systems market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Baxter, 3M, Abbott, Datwyler Holding Inc., Evonik, Astrazeneca, Novo Nordisk A/S, Corium Innovations, Inc., PolyActiva, Teleflex Incorporated, Elixir Medical, B. Braun SE, Nemera, Epion Therapeutics, Inc., Terumo Corporation, and Flowonix Medical Inc

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global advanced drug delivery systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global advanced drug delivery systems market

Market Segmentation

Type Insights
- Oral Drug Delivery System
- Injection-Based Drug Delivery System
- Inhalation/Pulmonary Drug Delivery System
- Transdermal Drug Delivery System
- Carrier Based Drug Delivery System
- Others (Transmucosal Drug Delivery System, etc.)
Application Insights
- Cardiovascular Diseases
- Oncology
- Urology
- Ophthalmology
- Inflammatory Diseases
- Others (Infectious Diseases, etc.)
Carrier Type Insights
- Liposomes
- Nanoparticles
- Microspheres
- Monoclonal Antibodies
End User Insights
- Hospitals
- Specialty Clinics
- Others (Research Institutes, etc.)
Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Baxter
- 3M
- Abbott
- Datwyler Holding Inc.
- Evonik
- Astrazeneca
- Novo Nordisk A/S
- Corium Innovations, Inc.
- PolyActiva
- Teleflex Incorporated
- Elixir Medical
- Braun SE
- Nemera
- Epion Therapeutics, Inc.
- Terumo Corporation
- Flowonix Medical Inc

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Advanced Drug Delivery Systems Market, By Type
- Advanced Drug Delivery Systems Market, By Application
- Advanced Drug Delivery Systems Market, By Carrier Type
- Advanced Drug Delivery Systems Market, By End User
- Advanced Drug Delivery Systems Market, By Region

3. Market Dynamics, Regulations, And Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Epidemiology

4. Advanced Drug Delivery Systems Market, By Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oral Drug Delivery System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Injection-Based Drug Delivery System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Inhalation/Pulmonary Drug Delivery System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Transdermal Drug Delivery System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Carrier Based Drug Delivery System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Transmucosal Drug Delivery System, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Advanced Drug Delivery Systems Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Urology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ophthalmology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Inflammatory Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Infectious Diseases, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Advanced Drug Delivery Systems Market, By Carrier Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Nanoparticles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Microspheres
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Advanced Drug Delivery Systems Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Research Institutes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Advanced Drug Delivery Systems Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Carrier Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Baxter
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
3M
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Datwyler Holding Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Evonik
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Astrazeneca
Novo Nordisk A/S
Corium Innovations, Inc.
PolyActiva
Teleflex Incorporated
Elixir Medical
Braun SE
Nemera
Epion Therapeutics, Inc.
Terumo Corporation
Flowonix Medical Inc

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

先进 DDS（药物传输系统）市场：按类型、按应用、按载体类型、按最终用户、按地区